Assertio Holdings, Inc.ASRTEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As o...
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Nantahala | 8.00% | 7.6M | — | 2024-02-14 |
| The Vanguard Group | 4.68% | 4.5M | flat | 2024-11-12 |
| BlackRock, Inc. | 1.50% | 1.4M | ▼ -5.40pp | 2024-07-08 |
| Armistice Capital, LLC | 0.00% | 4.5K | ▼ -6.13pp | 2024-11-14 |
| Percy Rockdale LLC | 0.00% | 4.5K | ▼ -1.00pp | 2024-02-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-02-21 | Ajay Patel | EVP and CFO | Option exercise | 1.1K | $0.00 | $0 |
| 2026-02-21 | Sam Schlessinger | EVP, General Counsel | Option exercise | 1.1K | $0.00 | $0 |
| 2026-02-21 | Paul Schwichtenberg | President and COO | Option exercise | 1.1K | $0.00 | $0 |
| 2026-02-18 | Sam Schlessinger | EVP, General Counsel | Option exercise | 2.8K | $0.00 | $0 |
| 2026-02-18 | Paul Schwichtenberg | President and COO | Option exercise | 2.8K | $0.00 | $0 |
| 2026-02-18 | Ajay Patel | EVP and CFO | Option exercise | 2.8K | $0.00 | $0 |
| 2026-02-07 | Paul Schwichtenberg | President and COO | Option exercise | 1.7K | $0.00 | $0 |
| 2026-02-07 | Ajay Patel | EVP and CFO | Option exercise | 1.7K | $0.00 | $0 |
| 2026-02-07 | Sam Schlessinger | EVP, General Counsel | Option exercise | 1.4K | $0.00 | $0 |
1–9 of 9